BE883495A - HYPOLIPEMIC MEDICINAL PRODUCT BASED ON CARNITINE - Google Patents

HYPOLIPEMIC MEDICINAL PRODUCT BASED ON CARNITINE

Info

Publication number
BE883495A
BE883495A BE2/58580A BE2058580A BE883495A BE 883495 A BE883495 A BE 883495A BE 2/58580 A BE2/58580 A BE 2/58580A BE 2058580 A BE2058580 A BE 2058580A BE 883495 A BE883495 A BE 883495A
Authority
BE
Belgium
Prior art keywords
hypolipemic
carnitine
product based
medicinal product
medicinal
Prior art date
Application number
BE2/58580A
Other languages
French (fr)
Original Assignee
Fresenius Chem Pharm Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Chem Pharm Ind filed Critical Fresenius Chem Pharm Ind
Publication of BE883495A publication Critical patent/BE883495A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
BE2/58580A 1979-05-29 1980-05-28 HYPOLIPEMIC MEDICINAL PRODUCT BASED ON CARNITINE BE883495A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792921852 DE2921852A1 (en) 1979-05-29 1979-05-29 LIPID LOWERING AGENT

Publications (1)

Publication Number Publication Date
BE883495A true BE883495A (en) 1980-09-15

Family

ID=6071966

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2/58580A BE883495A (en) 1979-05-29 1980-05-28 HYPOLIPEMIC MEDICINAL PRODUCT BASED ON CARNITINE

Country Status (5)

Country Link
BE (1) BE883495A (en)
CH (1) CH646056A5 (en)
DE (1) DE2921852A1 (en)
FR (1) FR2457689A1 (en)
GB (1) GB2052976A (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1120033B (en) * 1979-10-05 1986-03-19 Sigma Tau Ind Farmaceuti INCLUDING PHARMACEUTICAL COMPOSITION-CARNITINE SUITABLE FOR PARENTERAL FEEDING
ATE9436T1 (en) * 1980-06-09 1984-10-15 Leopold & Co. Chem. Pharm. Fabrik Gesellschaft M.B.H. SOLUTION FOR INFUSION TO PROTECT THE LIVER AND IMPROVE ITS FUNCTIONING AND METHODS OF PRODUCTION.
IT1157238B (en) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti USE OF 1-CARNITINA TO IMPROVE THE BIOCHEMICAL AND BEHAVIORAL PARAMENTS OF THE SENILE AGE
JPS6217A (en) * 1985-02-14 1987-01-06 Chugai Pharmaceut Co Ltd Stable active type vitamin d3 pharmaceutical
IT1190370B (en) * 1985-06-19 1988-02-16 Zambon Spa SOLID PHARMACEUTICAL COMPOSITION FOR ORAL USE
SE8701662L (en) * 1987-04-22 1988-10-23 Gelder Nico M Van SETTING AND AGENTS FOR TREATING NEUROLOGICAL DISEASES, EXAMPLE, MIGRAEN THROUGH THE OPERATION OF NERV CELLS
FR2609393A1 (en) * 1988-02-23 1988-07-15 Serobiologiques Lab Sa Composition which is useful, in particular, as a base material for the preparation of pharmaceutical, in particular dermatological and/or cosmetic, compositions, comprising a nitrogenous substance, in particular amino acids, oligo- or polypeptides, proteins, and their derivatives, and pharmaceutical or cosmetic composition thus prepared
IT1255039B (en) * 1992-03-11 1995-10-13 Sigma Tau Ind Farmaceuti USE OF L-CARNITINE IN THE TREATMENT OF HIV-SEROPOSITIVE PATIENTS PRESENTING CARNITINE DEFICIT.
GB9416921D0 (en) * 1994-08-22 1994-10-12 Conway Gitta C A nutritional preparation
DE19735126C1 (en) * 1997-08-13 1999-01-21 Infectopharm Arzneimittel Und Process for the preparation of an oral composition containing a zinc compound and its use for the treatment of colds
IT1305308B1 (en) 1999-03-26 2001-05-04 Biosint S P A HIGH-CONTENT GRANULATE OF L-CARNITINE OR ALCANOYL-L-CARNITINE, PARTICULARLY SUITABLE FOR THE PRODUCTION OF COMPRESSION TABS
CN1322860C (en) * 2004-08-31 2007-06-27 北京正大绿洲医药科技有限公司 Levo carnitine dropping pill and preparation thereof
US7572832B2 (en) * 2007-03-19 2009-08-11 Biolink Life Sciences, Inc. Non-hygroscopic L-carnitine salts
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3810994A (en) * 1972-06-01 1974-05-14 Ethyl Corp Method and composition for treating obesity
US3968241A (en) * 1972-11-06 1976-07-06 Defelice Stephen L Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof
DE2903558C2 (en) * 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Use of L-carnitine
IT1156741B (en) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti THERAPEUTIC APPLICATION OF CARNITINE AND SOME ACYLATED DERIVATIVES OF CARNITINE IN HEMODIALYSIS
IT1156769B (en) * 1978-05-25 1987-02-04 Sigma Tau Ind Farmaceuti THERAPEUTIC APPLICATION OF CARNITINE AND OTHER ACIL DERIVATIVES OF CARNITINE

Also Published As

Publication number Publication date
DE2921852A1 (en) 1980-12-11
CH646056A5 (en) 1984-11-15
GB2052976A (en) 1981-02-04
FR2457689A1 (en) 1980-12-26

Similar Documents

Publication Publication Date Title
BE854270A (en) ANTI-TUMOR MEDICINAL PRODUCT BASED ON LYSOLECITHIN-TYPE COMPOUND
NL7904013A (en) PHARMACEUTICAL PACKAGING.
DK153631C (en) medicament dispenser
FI800910A (en) PHARMACEUTICAL FORM 4-AMINO-3-QUINOLINCARBOXYLSYROR OCH-ESTRAR
BE839632A (en) ZINCIC SULFADIAZINE MEDICINAL PRODUCT
SE7709359L (en) PHARMACEUTICAL DOSAGE FORM
BE883495A (en) HYPOLIPEMIC MEDICINAL PRODUCT BASED ON CARNITINE
BE854925A (en) 12-AZAPROSTANOIC ACIDS USEFUL AS A MEDICINAL PRODUCT
BE844532A (en) MEDICINAL PRODUCT BASED ON A BENZOTHIADIAZOLE DERIVATIVE
FR2307541A1 (en) MEDICINAL PRODUCT BASED ON A POLYPEPTIDE
BE854171A (en) 2-IMINO-THIAZOLIDINES AND THIAZOLINS USEFUL AS MEDICINAL PRODUCTS
FR2313075A1 (en) MEDICINAL PRODUCT BASED ON L-PYROGLUTAMYL-L-HISTIDYL-L-PROLINAMIDE OR ITS SALTS
IT8019430A0 (en) LONG-RELEASE PHARMACEUTICAL FORMULATION.
IT7950715A0 (en) PHARMACEUTICAL COMPOSITIONS BASED ON ARYLTRIFLUOETHANOL
SE7614582L (en) CONNECTION CAPSULA FOR A DRUG BOTTLE E D
BE865369A (en) MEDICINAL PRODUCT BASED ON PHYSARYM EXTRACT
IT8149179A0 (en) N-(1-ALLYL-2-PYRROLIDINYL-METHYL)-2METHOXY-4-AMINO-5-METHYL-SULFAMMOYLBENZAAMIDE PROCEDURE FOR PRODUCING IT AND ITS APPLICATION AS A MEDICINAL PRODUCT
FR2342067A1 (en) MEDICINE BASED ON A DERIVATIVE OF QUINOLEINE
BE886309A (en) NEW MEDICINAL PRODUCT BASED ON ASPIRIN AND HEPTAMINOL
IT8025835A0 (en) PHTHALAZINOL. PHARMACEUTICAL COMPOSITION BASED ON
FR2333507A1 (en) MEDICINAL PRODUCT BASED ON SUBSTANCES HAVING THE SKELETON OF EBURNANE
FR2321280A1 (en) MEDICINAL PRODUCT BASED ON O-ACYL-2,3-DIARYL-3-HALOGENO-ACRYLALDOXIMES
FR2326188A1 (en) ACYL CYANOGUANIDINES USEFUL AS A MEDICINAL PRODUCT
RO83817A2 (en) MEDICINAL PRODUCT WITH ACTION SEDATIVE-HYPNOGENIC
RO77521A2 (en) ANTIRHUMATISMAL DRUG

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: DR. EDUARD FRESENIUS CHEMISCH-PHARMAZEUTISCHE IND

Effective date: 19880531